UBS Group’s Health Assurance Acquisition Corp. Warrants HAACW Stock Holding History

UBS Group’s Portfolio HAACW Stock Details HAACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-394	Closed	–	–	11607
2022 Q2	$0	Buy	+394	New	+$126	﹤0.01%	11550
2021 Q4	–	Sell	-7,086	Closed	-$7K	–	11152
2021 Q3	$7K	Buy	7,086 +6,830	+2,668%	+$8.93K	﹤0.01%	8376
2021 Q2	$0	Buy	+256	New	+$522	﹤0.01%	10139

Other funds holding HAACW

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return

DIG

Dragoneer Investment Group San Francisco, California $2.83B AUM 12.55% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Finepoint Capital Boston, Massachusetts $2.8B AUM 13.35% 1-Year Est. Return

MCM

Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

KIM LLC Wichita, Kansas $1B AUM 29.68% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

Brookfield Corp Toronto, Ontario, Canada $77B AUM 10.33% 1-Year Est. Return

UBS Group's HAACW Position: Q3 2022 in Review

UBS Group sold out of Health Assurance Acquisition Corp. Warrants (HAACW) in Q3 2022, closing a stake of 394 shares.

UBS Group first reported a position in HAACW in Q2 2021 and held it in 3 quarters. The position peaked at $7K in Q3 2021. 29 funds tracked by Wall St. Rank hold HAACW as of Q3 2022.

UBS Group reported no remaining Health Assurance Acquisition Corp. Warrants position as of Q3 2022 after selling out during the quarter.
UBS Group sold 394 Health Assurance Acquisition Corp. Warrants shares in Q3 2022.
UBS Group first reported a position in Health Assurance Acquisition Corp. Warrants in Q2 2021 and held it in 3 quarters.
UBS Group's Health Assurance Acquisition Corp. Warrants position peaked at $7K in Q3 2021.
29 funds tracked by Wall St. Rank held Health Assurance Acquisition Corp. Warrants as of Q3 2022.

Based on UBS Group's 13F filing for Q3 2022, filed 10 Nov 2022.